Protective Effect of Carnosine on Subcortical Ischemic Vascular Dementia in Mice

CNS Neuroscience and Therapeutics

Volumn 18, Issue 9, 2012, Pages 745-753

  Ma, Jing ^a   Xiong, Jia Yan ^a,b   Hou, Wei Wei ^a   Yan, Hai Jing ^a   Sun, Yun ^a   Huang, Shang Wei ^a   Jin, Le ^a   Wang, Ye ^a   Hu, Wei Wei ^a   Chen, Zhong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Carnosine; Cognitive impairment; Subcortical ischemic vascular dementia; White matter

Indexed keywords

CARNOSINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTAMINE; HISTIDINE; HISTIDINE DECARBOXYLASE; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MICROGLIA; MOUSE; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; SUBCORTICAL ISCHEMIC VASCULAR DEMENTIA; WHITE MATTER LESION;

ANIMALS; AVOIDANCE LEARNING; CARNOSINE; CORPUS CALLOSUM; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; HISTIDINE; HISTIDINE DECARBOXYLASE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MYELIN BASIC PROTEIN; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; RECOGNITION (PSYCHOLOGY);

EID: 84865793660     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2012.00362.x     Document Type: Article

References (49)

1. Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008;7: 812-826.
2. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008;4: 363-381.
3. Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X. N-Methyl D-Aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease. Curr Alzheimer Res 2012;9: 746-758.
4. Tomimoto H. Subcortical vascular dementia. Neurosci Res 2011;71: 193-199.
5. Taguchi A. Cell-based therapy for patients with vascular dementia. Psychogeriatrics 2011;11: 113-115.
6. Dong YF, Kataoka K, Toyama K, et al. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension 2011;58: 635-642.
7. Alvarez-Sabin J, Roman GC. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke 2011;42: 40-43.
8. Baskys A, Hou AC. Vascular dementia: pharmacological treatment approaches and perspectives. Clin Interv Aging 2007;2: 327-335.
9. Pantoni L. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. J Neurol Sci 2004;226: 67-70.
10. Frobose T, Kurz A. Early diagnosis and treatment of dementia. MMW Fortschr Med 2011;153: 86-89.
11. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008;88: 1183-1241.
12. Tiligada E, Kyriakidis K, Chazot PL, Passani MB. Histamine pharmacology and new CNS drug targets. CNS Neurosci Ther 2011;17: 620-628.
13. Dai H, Kaneko K, Kato H, et al. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci Res 2007;57: 306-313.
14. Dere E, De Souza-Silva MA, Topic B, Spieler RE, Haas HL, Huston JP. Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo- and ventro-striatal dopamine turnover. Learn Mem 2003;10: 510-519.
15. Huang YW, Chen Z, Hu WW, Zhang LS, Wu W, Ying LY, Wei EQ. Facilitating effect of histamine on spatial memory deficits induced by dizocilpine as evaluated by 8-arm radial maze in SD rats. Acta Pharmacol Sin 2003;24: 1270-1276.
16. Huang YW, Hu WW, Chen Z, et al. Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav Brain Res 2004;151: 287-293.
17. Xu LS, Fan YY, He P, Zhang WP, Hu WW, Chen Z. Ameliorative effects of histamine on spatial memory deficits induced by scopolamine infusion into bilateral dorsal or ventral hippocampus as evaluated by the radial arm maze task. Clin Exp Pharmacol Physiol 2009;36: 816-821.
18. Adachi N, Liu K, Arai T. Prevention of brain infarction by postischemic administration of histidine in rats. Brain Res 2005;1039: 220-223.
19. Hamami G, Adachi N, Liu K, Arai T. Alleviation of ischemic neuronal damage by histamine H2 receptor stimulation in the rat striatum. Eur J Pharmacol 2004;484: 167-173.
20. Lozada A, Munyao N, Sallmen T, Lintunen M, Leurs R, Lindsberg PJ, Panula P. Postischemic regulation of central histamine receptors. Neuroscience 2005;136: 371-379.
21. Sheng Y, Lee JH, Medhurst AD, et al. Preservation of cortical histamine H(3) receptors in ischemic vascular and mixed dementias. J Neurol Sci 2012;315: 110-114.
22. Jin CL, Yang LX, Wu XH, et al. Effects of carnosine on amygdaloid-kindled seizures in Sprague-Dawley rats. Neuroscience 2005;135: 939-947.
23. Babizhayev MA, Yegorov YE. Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro to the clinic. Recent Pat Drug Deliv Formul 2011;4: 198-230.
24. Kurata H, Fujii T, Tsutsui H, et al. Renoprotective effects of l-carnosine on ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 2006;319: 640-647.
25. Shen Y, He P, Fan YY, et al. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. Free Radic Bio Med 2010;48: 727-735.
26. Pekcetin C, Kiray M, Ergur BU, et al. Carnosine attenuates oxidative stress and apoptosis in transient cerebral ischemia in rats. Acta Biol Hung 2009;60: 137-148.
27. Min J, Senut MC, Rajanikant K, et al. Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia. J Neurosci Res 2008;86: 2984-2991.
28. Ohtsu H, Tanaka S, Terui T, et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001;502: 53-56.
29. Sarti C, Pantoni L, Bartolini L, Inzitari D. Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res 2002;136: 13-20.
30. Yasui F, Matsugo S, Ishibashi M, et al. Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice. Neurosci Lett 2002;334: 177-180.
31. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11: 47-60.
32. Wakita H, Ruetzler C, Illoh KO, Chen Y, Takanohashi A, Spatz M, Hallenbeck JM. Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model. J Cereb Blood Flow Metab 2008;28: 341-353.
33. Yoshizaki K, Adachi K, Kataoka S, Watanabe A, Tabira T, Takahashi K, Wakita H. Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp Neurol 2008;210: 585-591.
34. Yang G, Kitagawa K, Matsushita K, Mabuchi T, Yagita Y, Yanagihara T, Matsumoto M. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Res 1997;752: 209-218.
35. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004;35: 2598-2603.
36. Shibata M, Yamasaki N, Miyakawa T, et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 2007;38: 2826-2832.
37. Miu AC, Heilman RM, Pasca SP, et al. Behavioral effects of corpus callosum transection and environmental enrichment in adult rats. Behav Brain Res 2006;172: 135-144.
38. Coltman R, Spain A, Tsenkina Y, et al. Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 2010;32: 2324-e2327.
39. 12 on myelin basic protein expression in different parts of rat brain after repeated frontal cerebral ischemia reperfusion. Chin J Clin Rehabil 2005;9: 80-81.
40. Shen Y, Hu WW, Fan YY, et al. Carnosine protects against NMDA-induced neurotoxicity in differentiated rat PC12 cells through carnosine-histidine-histamine pathway and H(1)/H(3) receptors. Biochem Pharmacol 2007;73: 709-717.
41. Simone MJ, Tan ZS. The role of inflammation in the pathogenesis of delirium and dementia in older adults: a review. CNS Neurosci Ther 2011;17: 506-513.
42. Benarroch EE. Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease. Neurology 2009;72: 1779-1785.
43. Fleisher-Berkovich S, Abramovitch-Dahan C, Ben-Shabat S, Apte R, Beit-Yannai E. Inhibitory effect of carnosine and N-acetyl carnosine on LPS-induced microglial oxidative stress and inflammation. Peptides 2009;30: 1306-1312.
44. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 2007;38: 724-730.
45. Juurlink BH. Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev 1997;21: 151-166.
46. Bishop GM, Dringen R, Robinson SR. Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic Biol Med 2007;42: 1222-1230.
47. Haynes RL, Baud O, Li J, Kinney HC, Volpe JJ, Folkerth DR. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 2005;15: 225-233.
48. van Horssen J, Schreibelt G, Drexhage J, Hazes T, Dijkstra CD, van der Valk P, de Vries HE. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med 2008;45: 1729-1737.
49. Hipkiss AR. Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res 2009;57: 87-154.